Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
zoptarelin doxorubicin
.
Show all posts
Showing posts with label
zoptarelin doxorubicin
.
Show all posts
Tuesday, March 10, 2015
Final Phase 1 data of zoptarelin doxorubicin Phase 1/2 trial published in Clinical Cancer Research
›
Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") announced that an article on final data for the Phase 1 po...
Saturday, January 5, 2013
Aeterna Zentaris reaches SPA agreement with FDA for AEZS-108 Phase 3 trial in endometrial cancer
›
Aeterna Zentaris Inc. announced that it has reached an agreement with FDA on a Special Protocol Assessment ("SPA") for an upco...
›
Home
View web version
